The Comparison of Food and Supplement as Probiotic Delivery Vehicles

Critical Reviews in Food Science and Nutrition

Volumn 56, Issue 6, 2016, Pages 896-909

  Homayoni Rad, Aziz ^a   Vaghef Mehrabany, Elnaz ^a   Alipoor, Beitullah ^a   Vaghef Mehrabany, Leila ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

efficacy; health benefits; Probiotic products

Indexed keywords

BACTERIA; HEALTH;

CLINICAL TRIAL; DELIVERY VEHICLE; EFFICACY; HEALTH BENEFITS; HEALTHY SUBJECTS; PROBIOTIC PRODUCTS; PROBIOTICS;

FOOD MICROBIOLOGY;

PROBIOTIC AGENT;

DIETARY SUPPLEMENT; FOOD CONTROL; GASTROINTESTINAL DISEASE; HUMAN; IMMUNOLOGY; INTESTINE; METABOLIC SYNDROME X; MICROBIOLOGY;

DIETARY SUPPLEMENTS; FOOD MICROBIOLOGY; GASTROINTESTINAL DISEASES; HUMANS; INTESTINES; METABOLIC SYNDROME; PROBIOTICS;

EID: 84964237903     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2012.733894     Document Type: Review

References (97)

1. K.Aihara,, O.Kajimoto,, H.Hirata,, R.Takahashi, and Y.Nakamura, (2005). Effect of powdered fermented milk with lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J. Am. Coll. Nutr. 24(4):257–265.
2. A.Alizadeh,, A.Homayouni Rad, and M.R.Ehsani, (2008). Probiotic survival in yogurt made from ultrafiltered skim milk during refrigerated storage. Res. J. Biol. Sci. 3(10):1163–1165.
3. S.J.Allen,, E.G.Martinez,, G.V.Gregorio, and L.F.Dans, (2010). Probiotics for treating acute infectious diarrhea. Cochrane Libr. 11:1–124.
4. A.S.Andreasen,, N.Larsen,, T.Pedersen-Skovsgaard,, R.M.Berg,, K.Moller,, K.D.Svendsen,, M.Jakobsen, and B.K.Pedersen, (2010). Effects of lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Brit. J. Nutr. 104(12):1831–1838.
5. Anonymous. (2002). Guidelines for the evaluation of probiotics in food, Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report. Available at http://www.who.int/foodsafety/publications/fs_management/probiotics2/en. 1–11.
6. A.Ataie-Jafari,, B.Larijani,, H.Alavi Majd, and F.Tahbaz, (2009). Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic Subjects. Ann. Nutr. Met. 54:22–27.
7. A.M.Bakker-Zierikzee,, E.A.F.Tol,, H.Kroes,, M.S.Alles,, F.J.Kok, and J.G.Bindels, (2006). Fecal SIgA secretion in infants fed on pre- or probiotic infant formula. Pediatr. Allergy Immunol. 17:134–140.
8. M.Baron, (2009). A patented strain of bacillus coagulans increased immune response to viral challenge. Postgrad Med. 121(2):114–118.
9. S.Basu,, M.Chatterjee,, S.Ganguly, and P.K.Chandra, (2007). Efficacy of lactobacillus rhamnosus GG in acute watery diarrhea of Indian children: A randomized controlled trial. J. Pediatr. Child Health 43:837–842.
10. S.Basu,, D.K.Paul,, S.Ganguly,, M.Chatterjee, and P.K.Chandra, (2009). Efficacy of high dose lactobacillus rhamnosus GG in controlling acute watery diarrhea in Indian children. J. Clin. Gastroenterol. 43:208–213.
11. M.Bazrafshan, and A.Homayouni Rad, (2010). Effect of environmental stress factors on the survival of lactobacillus acidophilus: A review. Microbial Biotechnol. J. Islamic Azad Univ. 2(6):47–56.
12. A.Berggren,, I.L.Ahren,, N.Larsson, and G.Onning, (2011). Randomized double blind and placebo controlled study using new probiotic lactobacilli for strengthening the body immune defense against viral infections. Eur. J. Nutr. 50:203–2010.
13. V.Briand,, P.Buffet,, S.Genty,, K.Lacombe,, N.Godineau,, J.Salomon,, E.Vandemelbrouck,, P.Ralaimazava,, C.Goujon,, S.Matheron,, A.Fontanet, and O.Bouchaud, (2006). Absence of efficacy of nonviable lactobacillus acidophilus for the prevention of traveler's diarrhea: a randomized, double-blind, controlled study. Clin. Infect. Dis. 43:1170–1175.
14. M.Brink,, M.Senekal, and L.M.T.Dicks, (2005). Market and product assessment of probiotic/prebiotic-containing functional foods and supplements manufactured in South Africa. J. Afr. Med. J. 95:114–119.
15. R.Caesar,, F.Fak, and F.Bached, (2010). Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J. Intern. Med. 268:320–328.
16. R.B.Canani,, P.Cirillo,, G.Terrin,, L.Cesarano,, M.I.Spagnuolo,, A.De Vincenzo,, F.Albano,, A.Passariello,, G.De Marco,, F.Manguso, and A.Guarino, (2007). Probiotics for treatment of acute diarrhea in children: randomized clinical trial of five different preparations. BMJ. 335(7615):340–345.
17. C.P.Champagne,, R.P.Ross,, M.Saarela,, K.F.Hansen, and D.Charalampopoulos, (2011). Recommendations for the viability assessment of probiotics as concentrated cultures and in food matrices. Int. J. Food Microbiol. 149:185–193.
18. B.J.Chang,, S.U.Park,, Y.S.Jang,, S.H.Ko,, N.M.Joo,, S.I.Kim,, C.H.Kim, and D.K.Chang, (2011). Effect of functional yogurt NY-YP901 in improving the trait of metabolic syndrome. Euro. J. Clin. Nutr. 65:1250–1255.
19. O.B.Chaudhri,, K.Wynne, and S.R.Bloom, (2008). Can gut hormones control appetite and prevent obesity? Diab. Care 31(2):S284–S289.
20. C.C.Chen,, M.S.Kong,, M.W.Lai,, H.C.Chao,, K.W.Chang,, S.Y.Chen,, Y.C.Huang,, C.H.Chiu,, W.C.Li,, P.Y.Lin,, C.J.Chen, and T.Y.Li, (2010). Probiotics have clinical, microbiological and immunological efficacy in acute infectious diarrhea. Pediatr. Infec.t Dis. J. 29:135–138.
21. I.Chitapanarux,, T.Chitapanarux,, P.Traisathit,, S.Kudumpee,, E.Tharavichitkul, and V.Lorvidhaya, (2010). Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat. Oncol. 5:31–36.
22. H.R.Christensen,, C.N.Larsen,, P.Kaestel,, L.B.Rosholm,, C.Sternberg,, K.F.Michaelsen, and H.Frokiaer, (2006). Immunomodulating potential of supplementation with probiotics: a dose response study in healthy young adults. Immunol. Med. Microbiol. 47:380–390.
23. J.P.Choraqui,, L.D.Van Egroo, and M.C.Fichot, (2004). Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings. J. Pediatr. Gastroenterol. Nutr. 38(3):288–292.
24. H.Costa-Riberio,, T.C.M.Riberio,, A.P.Mattos,, S.S.Valois,, D.A.Neri,, P.Almeida,, C.M.Cerqueira,, E.Ramos,, R.J.Young, and J.A.Vanderhoof, (2003). Limitations of probiotic therapy in acute, severe dehydrating diarrhea. J. Pediat. Gastroenterol. Nutr. 36:112–115.
25. B.Cukrowska,, R.Lodlnova-Zadnlkova,, C.Enders,, U.Sonnenborn,, J.Schulze, and H.Tlaskalova-Hogenova, (2002). Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917. Scand. J. Immunol. 55:204–209.
26. V.Delcenserie,, D.Martel,, M.Lamoureux,, J.Amiot,, Y.Boutin, and D.Roy, (2008). Immunomodulatory effects of probiotics in the intestinal tract. Curr. Issues Mol. Biol. 10:37–54.
27. M.Del Piano,, S.Garmagnola,, M.Ballare,, M.Sartori,, M.Orsello, and M.Balzarini, (2011). Is microencapsulation the future of probiotic preparations? Gut Microbes. 2(2):120–123.
28. N.M.Delzenne, and P.D.Cani, (2010). Nutritional modulation of gut microbiota in the context of obesity and insulin resistance: potential interest of prebiotics. Int. Dairy J. 20:277–280.
29. M.De Vrese,. and J.Schrezenmeir, (2008). Probiotics, prebiotics and synbiotics. Adv. Biochem. Engin/Biotechnol. 111:1–66.
30. M.De Vrese,., A.Stegelmann,, B.Richter,, S.Fenselau,, C.Laue,, J.Schrezenmeir,, (2001). Am J Clin Nutr. 73:421S–429S.
31. M.De Vrese,, P.Winkler,, P.Rautenberg,, T.Harder,, C.Noah,, C.Laue,, S.Ott,, J.Hampe,, S.Schreiber,, K.Heller, and J.Schrezenmeir, (2005). Effect of lactobacillus gasseri PA 16/8, bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind randomized, controlled trial. Clin. Nutr. 24:481–491.
32. L.De Vuyst,. (2000). Technology aspects related to the application of functional starter cultures. Food Technol. Biotechnol. 38(2):105–112.
33. B.B.Duncan,, M.I.Schmidt,, J.S.Pankow,, C.M.Ballantyne,, D.Couper,, A.Vigo,, R.Hoogeveen,, A.R.Folsom, and G.Heiss, (2003). Low-grade systemic inflammation and the development of type 2 diabetes. Diabetes. 52:1799–1805.
34. H.S.Ejtahed, and A.Homayouni Rad, (2010). Effects of probiotics on the prevention and treatment of gastrointestinal disorders. Microbial Biotech. J. Islamic Azad Univ. 2(4):53–60 [Persian].
35. H.S.Ejtahed,, J.Mohtadi-Nia,, A.Homayouni-Rad,, M.Niafar,, M.Asghari-Jafarabadi, and V.Mofid, (2011a). Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition. 28(5):539–543.
36. H.S.Ejtahed,, J.Mohtadi Nia,, A.Homayouni Rad,, M.Niafar,, M.Asghari, and V.Mofid, (2011b). The effects of probiotic and conventional yogurt on diabetes markers and insulin resistance in type 2 diabetes patients: A randomized controlled clinical trial. Iranian J Endocrinol Metabolism. 13(1):1–8.
37. H.S.Ejtahed,, J.Mohtadi-Nia,, A.Homayouni Rad,, M.Niafar,, M.Asghari-Jafarabadi,, V.Mofid, and A.Akbarian-Moghari, (2010). Effects of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci. 94:3288–3294.
38. E.R.Farnworth, (2008). Handbook of fermented functional foods (Functional Foods and Nutraceuticals), pp. 26–54. Taylor and Francis, New York.
39. H.S.Gill,, K.J.Rutherfurd,, M.Cross, and P.Gopal, (2001). Enhancement of immunity in the elderly by dietary supplementation with the probiotic bifidobacterium lactis HN019. Am J Clin Nutr. 74:833–839.
40. S.Guandalini,, L.Pensabene,, M.A.Zikri,, J.A.Dias,, L.G.Casali,, H.Hoekstra,, S.Kolacek,, K.Massar,, D.Micetic-Turk,, A.Papadopoulou,, J.S.de Sousa,, B.Sandhu,, H.Szajewska, and Z.Weizman, (2000). Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: A multicenter European trial. J. Pediat. Gastroenterol. Nutr. 30(1):54–60.
41. K.Hatakka,, M.Mutanen,, R.Holma,, M.Saxelin, and R.Korpela, (2008). Lactobacillus rhamnosus LC705 together with propionibacterium freudenreichii ssp shermanii JS administered in capsules is ineffective in lowering serum lipids. J. Am. Coll. Nutr. 27(4):441–447.
42. T.He,, M.G.Priebe,, Y.Zhong,, C.Huang,, H.J.Harmsen,, G.C.Raangs,, J.M.Antoine,, G.W.Welling, and R.J.Vonk, (2008). Effects of yogurt and bifidobacteria supplementation on the colonic microbiota in lactose-intolerant subjects. J. Appl. Microbiol. 104:595–604.
43. A.Homayouni Rad, (2008). Therapeutical effects of functional probiotic, prebiotic and synbiotic foods. Tabriz University of Medical Sciences, Tabriz [Persian].
44. A.Homayouni Rad,, M.R.Ehsani,, A.Azizi,, S.H.Razavi, and M.S.Yarmand, (2008a). Growth and survival of some probiotic strains in simulated ice cream conditions. J. Appl. Sci. 8(2):379–382.
45. A.Homayouni Rad,, A.Azizi,, M.R.Ehsani,, M.S.Yarmand, and S.H.Razavi, (2008b). Effect of microencapsulation and resistant starch on the probiotic survival and sensory properties of synbiotic ice cream. Food Chem. 111:50–55.
46. A.Homayouni Rad,, M.R.Ehsani,, A.Azizi,, S.H.Razavi, and M.S.Yarmand, (2008c). Spectrophotometrically evaluation of probiotic growth in liquid media. Asia. J. Chem. 20(3):2414–2420.
47. D.B.Hughes, and D.G.Hoover, (1995). Viability and enzymatic activity of bifidobacteria in milk. J Dairy Sci, 78(2):268–276.
48. N.Ishibashi, and S.Shimamura, (1993). Bifidobacteria: Research and development in Japan. Food Technol. 47(6):126, 129–134.
49. G.Jahreis,, H.Vogelsang,, G.Kiessling,, R.Schubert,, C.Bunte, and W.P.Hammes, (2002). Influence of probiotic sausage (lactobacillus paracasei) on blood lipids and immunological parameters of healthy volunteers. Food Res. Int. 35:133–138.
50. Y.Kadooka,, M.Sato,, K.Imaizumi,, A.Ogawa,, K.Ikuyama,, Y.Akai,, M.Okano,, M.Kagoshima, and T.Tsuchida, (2010). Regulation of abdominal adiposity by probiotics (lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur. J. Clin Nutr. 64:636–643.
51. K.Kailasapathy, and J.Chin, (2000). Survival and therapeutic potential of probiotic organisms with reference to lactobacillus acidophilus and bifidobacterium spp. Immunol. Cell Biol. 78:80–88.
52. H.R.Kianifar,, R.Farid,, H.Ahanchian,, F.Jabbari,, T.Moghiman, and A.Sistanian, (2009). Probiotics in the treatment of acute diarrhea in young children. Iran J. Med. Sci. 34(3):204–207.
53. A.Klein,, U.Friedrich,, H.Vogelsang, and G.Jahreis, (2008). Lactobacillus acidophilus 74-2 and bifidobacterium animalis subsp. lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. Eur. J. Clin. Nutr. 62:584–593.
54. S.Kolida,, K.Tuohy, and G.R.Gibson, (2000). The human gut flora in nutrition and approaches for its dietary modulation. British Nutr. Found. Nutition Bull. 25:223–231.
55. K.Kowalska-Duplaga,, K.Fyderek,, H.Szajewska, and R.Janiak, (2004). Efficacy of Trilac® in the treatment of acute diarrhea in infants and young children-a multicentre, randomized, double-blind placebo-controlled study. Pediatria Wspóczesna, Gastroenterologia, Hepatologia iywienie Dziecka. 6(3):295–299.
56. H.M.Lakka,, D.E.Laaksonen,, T.A.Lakka,, L.K.Niskanen,, E.Kampusalo,, J.Tuomilehto, and J.T.Salonen, (2002). The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 288:2709–2716.
57. S.Lebeer,, J.Vanderleyden, and S.C.J.Keersmaecker, (2010). Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat. Rev. Microbiol. 8:171–184.
58. M.C.Lee,, L.H.Lin,, K.L.Hung, and H.Y.Wu, (2001). Oral bacterial therapy promotes recovery from acute diarrhea in children. Acta Paediatr Taiwan. 42(5):301–305.
59. V.Lei,, H.Friis, and K.Fleisher Michaelsen, (2006). Spontaneously fermented millet product as a natural probiotic treatment for diarrhea in young children: an intervention study in North Ghana. Int. J. Food Mcrobiol. 110:246–253
60. K.M.Levri,, K.Ketvertis, and M.Deramo,, J.H.Merenstein,, F.Damico, (2005). Do probiotics reduce adult lactose intolerance? J. Fam. Prac. 54(7):613–620.
61. S.J.Lewis, and S.Burmeister, (2005). A double-blind placebo-controlled study of the effects of lactobacillus acidophilus on plasma lipids. Eur. J. Clin. Nutr. 59:776–780.
62. R.E.Ley, (2010). Obesity and the human microbiome. Curr. Opin. Gastroenterol. 26:5–11.
63. A.Lourens-Hattingh, and B.C.Viljoen, (2001). Yogurt as probiotic carrier food. Int. Dairy J. 11:1–17.
64. H.S.Lye,, C.Y.Kuan,, J.A.Ewe,, W.Y.Fung, and M.T.Liong, (2009). The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin and phytoesterogens. Int. J Dairy Sci. 10:3755–3775.
65. J.Mane,, E.Pedrosa,, V.Loren,, M.A.Gassull,, J.Espadaler,, J.Cune,, S.Audivert,, M.A.Bonachera, and E.Cabre, (2011). A mixture of lactobacillus plantarum CECT 7315 and CECT 7316 enhances systemic immunity in elderly subjects. A dose-response, double-blind, placebo-controlled, randomized pilot trial. Nutr. Hosp. 26(1):228–235.
66. A.Martinez-Canavate,, S.Sierra,, F.Lara-Villoslada,, J.Romero,, J.Maldonado,, J.Boza,, J.Xaus, and M.Olivares, (2009). A probiotic dairy product containing L. gasseri CECT5714 and L. coryniformis CECT5711 induces immunological changes in children suffering from allergy. Pediatr. Allergy Immunol. 20:592–600.
67. L.V.Mcfarland, (2006). Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of clostridium difficile disease. Am. J. Gastroenterol. 101:812–822.
68. G.Musso,, R.Gambino, and M.Cassader, (2010). Obesity, diabetes and gut microbiota. Diabetes Care. 33:2277–2284.
69. A.Mustapha,, T.Jiang, and D.A.Savaiano, (1997). Improvement of lactose digestion by humans following ingestion of unfermented acidophilus milk: influence of bile sensitivity, lactose transport and acid tolerance of lactobacillus acidophilus. J. Dairy Sci. 80:1537–1545.
70. M.Naruszewicz,, M.L.Johansson,, D.Zapolska-Downar, and H.Bukowska, (2002). Effect of lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am. J. Clin. Nutr. 76:1249–1255.
71. M.Nermes,, J.M.Kantele,, T.J.Atosuo,, S.Salminen, and E.Isolauri, (2010). Interaction of orally administered lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis. Clin. Exp. Allergy. 41:370–377.
72. M.Olivares,, M.P.Diaz-Ropero,, N.Gomez,, F.Lara-Villoslada,, S.Sierra,, J.A.Maldonado,, R.Martin,, J.M.Rodriguez, and J.Xaus, (2006). The consumption of two new probiotic strains, lactobacillus gasseri CECT 5714 and lactobacillus coryniformis CECT 5711, boosts the immune system of healthy humans. Int. Microbiol. 9:47–52
73. L.G.Ooi, and M.T.Liong, (2010). Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int. J. Mol. Sci. 11:2499–2522.
74. M.D.Parra,, B.E.M.Martinez de Morentin,, J.M.Cobo,, A.Mateos, and J.A.Martínez, (2004). Daily ingestion of fermented milk containing lactobacillus casei DN114001 improves innate-defense capacity in healthy middle-aged people. J. Physiol. Biochem. 60(2):85–91.
75. C.A.Pendone,, A.O.Bernabeu,, E.R.Postaire,, C.F.Bouley, and P.Reinert, (2000). The effect of supplementation with milk fermented by lactobacillus casei on acute diarrhea in children attending day care centers. Int. J. Clin. Prac. 53(3):179–184.
76. Pedone, C. A., Arnaud, C. C., Postaire, E. R., Bouley, C. F. and Reinert, P. (2000). Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea. Int. J. Clin. Pract. 54(9):568–571.
77. J.C.Pickup, (2004). Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 27:813–823.
78. N.H.Rampengan,, J.Manoppo, and S.M.Warouw, (2010). Comparison of efficacies between live and killed probiotics in children with lactose malabsorption. Southern Asian J. Trop. Med. Public Health 41(2):474–481.
79. R.D.C.S.Ranadheera,, S.K.Baines, and M.C.Adams, (2010). Importance of food in probiotic efficacy. Food Res. Int. 43:1–7.
80. M.Rinne,, M.Kalliomaki,, H.Arvilommi,, S.Salminen, and E.Isolauri, (2005). Effect of probiotics and breastfeeding on the bifidobacterium and lactobacillus/enterococcus microbiota and humoral immune responses. J. Pediatr. 147:186–191.
81. B.K.Ritchie,, D.R.Brewster,, C.D.Tran,, G.P.Davidson,, Y.McNeil, and R.N.Butler, (2010). Efficacy of lactobacillus GG in aboriginal children with acute diarrheal disease: a randomized clinical trial. JPGN. 50:619–624.
82. V.Rosenfeldt,, K.F.Michaelsen,, M.Jakobsen,, C.N.Larsen,, P.L.Moller,, P.Pedersen,, M.Tvede,, H.Weyrehter,, N.H.Valerius, and A.Paerregaard, (2002). Effect of probiotic lactobacillus strains in young children hospitalized with acute diarrhea. Pediatr. Infect. Dis. J. 21(5):411–416.
83. Y.Sanz,, A.Santacruz, and P.Gauffin, (2010). Probiotics in the defense and metabolic balance of the organism, gut microbiota in obesity and metabolic disorders. Proc. Nutr. Soc. 69:434–441.
84. K.Saraf,, M.C.Shashikanth,, T.Priya,, N.Sultana, and N.C.S.K.Chaitanya, (2010). Probiotics—Do they have a role in medicine and dentistry? JAPI. 58:488–492.
85. S.A.Sarker,, S.Sultana,, G.J.Fuchs,, N.H.Alam,, T.Azim,, H.Brussow, and L.Hammarstrom, (2005). Lactobacillus paracasei strain ST11 has no effect on rotavirus but ameliorates the outcome of nonrotavirus diarrhea in children from Bangladesh. Pediatrics. 116:221–228.
86. M.Saxelin,, A.Lassig,, H.Karjalainen,, S.Tynkkyen,, A.Surakk, and H.Vapaatalo, (2010). Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yogurt or cheese. Int. J Food Microbiol. 144:293–300.
87. S.Seifert,, A.Bub,, C.M.Franz, and B.Watzl, (2011). Probiotic lactobacillus casei Shirota supplementation does not modulate immunity in healthy men with reduced natural killer cell activity. J. Nutr. 141(5):978–984.
88. S.Sierra,, F.Lara-Villoslada,, L.Sempere,, M.Olivares,, J.Boza, and J.Xaus, (2010). Intestinal and immunological effects of daily oral administration of lactobacillus salivarius CECT5713 to healthy adults. Anaerobe. 16:195–200.
89. L.A.Simons,, S.G.Amansec, and P.Conway, (2006). Effect of lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol. Nutr., Metab. Cardiovasc. Dis. 16:531–535.
90. R.D.Sleator, and C.Hill, (2008). New frontiers in probiotic research. Lett. Appl. Microbiol. 46:143–147.
91. V.Stadlbauer,, R.P.Mookerjee,, S.Hodges,, G.A.K.Wright,, N.A.Davies, and R.Jalan, (2008). Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J. Hepatol. 48:945–951.
92. H.Szymanski,, J.Pejcz,, M.Jawien,, A.Chmielarczyk,, M.Strus, and P.B.Heczko, (2005). Treatment of acute infectious diarrhea in infants and children with a mixture of three lactobacillus rhamnosus strains- a randomized, double-blind, placebo-controlled trial. Alim. Pharmacol. Ther. 23:247–253.
93. Szymanski, H., Pejcz, J., Jawien, M., Chmielarczyk, A., Strus, M. and Heczko, P. B. (2006). Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains-a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol. Ther. 23:247–253.
94. L.Trois,, E.M.Cardoso, and E.Miura, (2008). Use of probiotics in HIV-infected children: A randomized double-blind controlled study. J. Tropical. Pediatr. 54(1):19–24.
95. B.Vivatvakin, and E.Kowitdamrong, (2006). Randomized control trial of live lactobacillus acidophilus plus bifidobacterium infantis in treatment of infantile acute watery diarrhea. J. Med. Assoc. Thai. 3:126–133.
96. J.Z.Xiao,, S.Kondo,, N.Takahashi,, K.Miyaji,, K.Oshida,, A.Hiramatsu,, K.Iwatsuki,, S.Kokubo, and A.Hosono, (2003). Effects of milk products fermented by bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J. Dairy Sci. 86:2452–2461.
97. R.Yesovitch,, A.Cohen, and A.Szilagyi, (2004). Failure to improve parameters of lactose maldigestion using the multi probiotic product VSL3 in lactose maldigesters: a pilot study. Can J. Gastroenterol. 18(2):83–86.